Skip to main content
SpringerLink
Log in

Stopping TNF inhibitors worth considering in stable RA

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Potential Optimalisation of Expediency and Effectiveness of TNFis

Reference

  • Tran-Duy A, et al. An Economic Evaluation of Stopping versus Continuing TNF-Inhibitor Treatment in Rheumatoid Arthritis Patients in Remission or Low Disease Activity: results from the POET randomized trial. Arthritis and Rheumatology : 9 May 2018. Available from: URL: http://doi.org/10.1002/art.40546

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stopping TNF inhibitors worth considering in stable RA. PharmacoEcon Outcomes News 804, 32 (2018). https://doi.org/10.1007/s40274-018-4996-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-4996-x

Search

Navigation